Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

In addition to Wegovy, incretin mimetics FDA-approved ... Safe Medicines went so far as to implore Fox not to broadcast the commercial. The fallout has become political, too.

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Covering some 1.9million people in the UK, private health insurer Vitality has become the country’s first provider to offer customers discounted weight-loss treatments, such as Wegovy and Mounjaro.

The strong sales of Wegovy and fellow weight loss treatment ... “In 2025, we will continue our focus on commercial execution, on the progression of our early and late-stage R&D pipeline and ...